Showing results (51-60 of 132) with videos related to

Sort By:
Pageof 14
International Journal of Antimicrobial Agents|May 16, 2006
Evaluation of dalbavancin in combination with nine antimicrobial agents to detect enhanced or antagonistic interactionsDavid M Johnson, Thomas R Fritsche, Helio S Sader, et al.
The Journal of Antimicrobial Chemotherapy|April 2, 2004
Potential utility of a peptide deformylase inhibitor (NVP PDF-713) against oxazolidinone-resistant or streptogramin-resistant Gram-positive organism isolatesRonald N Jones, Gary J Moet, Helio S Sader, et al.
International Journal of Antimicrobial Agents|August 4, 2004
Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001)Jennifer M Streit, Ronald N Jones, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|August 18, 2004
Antimicrobial resistance rates and clonality results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) programme: report of year five (2003)Paul R Rhomberg, Ronald N Jones, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|February 7, 2006
Microbiologic characterization of isolates from a dalbavancin clinical trial for catheter-related bloodstream infectionsBeth P Goldstein, Ronald N Jones, Thomas R Fritsche, et al.
Diagnostic Microbiology and Infectious Disease|October 3, 2007
Zyvox Annual Appraisal of Potency and Spectrum Program Results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from 16 countriesRonald N Jones, Thomas R Fritsche, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|April 6, 2007
Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC valuesRonald N Jones, Thomas R Fritsche, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|June 1, 2005
Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogensJennifer M Streit, Helio S Sader, Thomas R Fritsche, et al.
Diagnostic Microbiology and Infectious Disease|March 15, 2006
Activity of gatifloxacin tested against isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (North America, 1998-2003)Kelley A Fedler, Ronald N Jones, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|January 8, 2008
In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureusThomas R Fritsche, Paul R Rhomberg, Helio S Sader, et al.
Pageof 14